Living with Pancreatic Cancer
730 articles
Can I exercise? How can I cope with stress and anxiety? Learn more here.
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
Identifying Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Meet the Researcher: Arnav Mehta, M.D., Ph.D.
Dr. Arnav Mehta combines mathematics and medicine in his search to improve options for gastrointestinal cancer patients. Learn about his groundbreaking work.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
Let’s Learn Webinar on Clinical Trials on October 28th
Join Let’s Win for a webinar on the Importance of Clinical Trials, to learn more about participating in a trial as part of treatment.
Let’s Win Rings the Nasdaq Closing Bell for Pancreatic Cancer Awareness Month
Let’s Win marked Pancreatic Cancer Awareness Month by ringing the closing bell at the Nasdaq Stock Market on Monday November 12, 2018.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.